Señales en vivo de IEIH | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 ago 2022 @ 15:53):

The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies...

Stats
Volumen de hoy	7 023.00
Volumen promedio	0.00
Capitalización de mercado	36.79M
EPS	$0.357 ( 2023-09-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.440 (1.29%)

Volumen Correlación

Largo: 0.15 (neutral)

Corto: 0.00 (neutral)

Signal:(53.667) Neutral

iShares Evolved U.S. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iShares Evolved U.S. Correlación - Moneda/Commodity

-0.34
( neutral )

0.23
( neutral )

0.32
( neutral )

-0.35
( neutral )

-0.45
( neutral )

-0.50
( neutral )

iShares Evolved U.S. Finanzas

Annual	2022
Ingresos:	$878.24M
Beneficio Bruto:	$794.08M (90.42 %)
EPS:	$1.800

FY	2022
Ingresos:	$878.24M
Beneficio Bruto:	$794.08M (90.42 %)
EPS:	$1.800

Financial Reports:

No articles found.

iShares Evolved U.S.

The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.